The pharmacy department is committed to Parkview’s American Society of Health-System Pharmacists (ASHP) accredited PGY1 Pharmacy Practice Residency and PGY2 Ambulatory Care Pharmacy Residency which focus on evidence-based patient care and research opportunities for clinical questions within our patient population. Residents complete a process improvement project with poster presentation at ASHP Midyear Clinical Meeting and a major research project with results presented at Great Lakes Pharmacy Resident Conference.
For more information about our pharmacy residency programs, please visit: Pharmacy Residency Program
Submissions from 2022
Medication Use Evaluation of Angiotensin II, Kevin Baumgartner PharmD; Dustin D Linn PharmD, BCCCP; and Michael Todt PharmD
Development of a Tool to Assess Hypoglycemia Risk in Patients with Type 2 Diabetes, Katherine Brown PharmD
Osteoporosis: Closing Gaps In Care To Improve Value-Based Contract Measure Outcomes, Zachary Brown PharmD
Evaluation of Intravenous Loop Diuretic Use in Acute Decompensated Heart Failure in a Community Hospital, Catherine Eichler PharmD; Cole Luty PharmD; and Kris Howard PharmD, AACC
Ketorolac Ceiling Dose Implementation in the Emergency Department, Abigail Geyer PharmD
Implementing Services for Pediatric Cystic Fibrosis Treatment in a Community Hospital, Paige M. Grube PharmD
Characterizing Appropriate Use of Octreotide Continuous Infusions for Gastroesophageal Bleeding, Austin Harris PharmD; Curtis Stump PharmD; and Luke Keller PharmD, BCPS, BCCCP
Evaluation of a Pharmacist-Led Health Literacy Workflow in the Ambulatory Clinic, Alexis Mann PharmD, MBA
Impact of Specialty Pharmacy Services on Pneumococcal Vaccination Rates in a Large Inflammatory Bowel Disease Population, Jessica Offerle PharmD; Tara Jellison PharmD, MBA,FASHP; Michele Walters PharmD, BCPS, BCIDP; and Toni Zahorian PharmD, BCACP
Safety of 10,000 Unit Unfractionated Heparin Boluses for Acute Myocardial Infarction in the Emergency Department, Emma Pastula PharmD; Sarah Meeks PharmD; Amber Ooley PharmD, BCPS, BCCCP; and Sarah Ferrell PharmD
Impact of Pharmacist-Led Direct Oral Anticoagulant Monitoring on Appropriate Medication Use, Bhavika Patel PharmD; Kenneth Wiley PharmD, BCACP; and Alicia Sawmiller PharmD, BCACP
Evaluation of a Pharmacy-Led Statin Medication Use Review and Outreach Initiative, Megan Wagner PharmD
Comparison of Clinical Pharmacist Versus Nurse Led Medicare Annual Wellness Visits in the Primary Care Clinic Setting, Payton Waltz PharmD; Erin Copi PharmD, BCACP; and Rachel Steele PharmD, BCACP
Submissions from 2021
Assessing Consistency with Standards of Care Recommendations for Patients with Type 2 Diabetes at Hospital Discharge, Katherine Brown PharmD; Timothy L. Johnston BPharm, PharmD, BCPS, BCCCP; and Andrea Sloat PharmD
Comparison of Standard Dose vs Higher Dose Low Molecular Weight Heparin and Unfractionated Heparin for DVT Prophylaxis in COVID-19 Patients, Zachary Brown PharmD; Munyaradzi Chakabva MD; Tabinda Akhtar MD; Sarah Polina PharmD, BCPS; Michael Todt PharmD, BCCCP; Mckenna Brauner NP; Meghan McGuire NP; and Aws Polina MD
Characterization of Infliximab and Biosimilar Use in a Community Health System, Abigail Geyer PharmD; Luke Keller PharmD, BCPS, BCCCP; Curtis Stump PharmD; and Renu Johnson PharmD, BCPS
Evaluation of Benefits Associated with Chemotherapy Dose-Banding Practices, Alexis Mann PharmD, MBA; Kyle Becker PharmD, MBA, BCOP; and Jesse Christman PharmD, BCOP
Pharmacist Impact on Cardiology Bundle Payments for Care Improvement and Patient Outcomes, Megan Wagner PharmD; Jordan Holder PharmD; and Priya Verma PharmD, BCACP
Evaluation of Emergency Department Treatment of Pediatric Asthma Exacerbations, Paige Walker PharmD; Amber Ooley PharmD, BCPS, BCCCP; and Kassandra Foellinger PharmD, BCPS
Submissions from 2020
Appropriateness of intravenous acetaminophen use in the emergency departments across a multi-hospital community health system, Allison Clemens PharmD, Sarah Meeks PharmD, and Bryan Statz PharmD
Implementation of a Pediatric Pharmacy Education Program at a Community Regional Medical Center., Chelsea L Ferguson PharmD, Sarah Ferrell PharmD, Karen Kovey PharmD, Joanna Young, and Sara Trovinger
Impact of Extended Interval INR Testing During the COVID-19 Pandemic, Jordan Holder PharmD; Maryam Noureldin PharmD, BCPS,BCACP; and Priya Verma PharmD
Evaluation of dexmedetomidine use as an adjunctive therapy in the management of alcohol withdrawal syndrome, Zsanett Kormanyos PharmD; Dustin D. Linn PharmD, BCPS, BCCCP; and Jillian Coons PharmD, BCPS
Characterization of antibiotic use and culture data in COVID-19 pandemic patients, Ashley Logan PharmD; Stacy Clore PharmD, BCPS; and Alissa Keillor PharmD
Evaluation of pharmacy to dose heparin protocol in neurological conditions, Leslie Siegel PharmD; Timothy L. Johnston PharmD; and Karen Dunkelberger BS Pharm, MSHI, CPPS
Assessing duration of therapy recommendations based on Clostridium difficile guidelines within the Parkview health system, Curtis Stump PharmD; Trent Towne PharmD, BCPS; and Aubrey Mills PharmD
Submissions from 2019
Evaluation of an adjusted body weight based heparin protocol, Jenna Deininger PharmD; Elizabeth Meisberger PharmD, BCPS; and Kris Howard PharmD, BCPS
Time to achievement of mean arterial pressure goal in patients with septic shock based on initial norepinephrine dose, Meagan R. Ellinger PharmD; Dustin D Linn PharmD, BCPS, BCCCP; and Michael Todt PharmD, BCCP
Impact of atypical antipsychotics on sedation requirements in mechanically ventilated, critically ill patients, Michael Genday PharmD; Dustin D Linn PharmD, BCPS, BCCCP; and Jim Roy PharmD, BCPS, BCCCP
Assessing appropriateness of inpatient rifaximin use in a community health system, Alissa Keillor PharmD; Sarah Pfaehler PharmD, MBA, BCPS; and Lorin Yolch PharmD, BCGP, BCAC
Impact of a Primary Care Pharmacist Utilizing a Team-Based Model of Care, Priya Verma PharmD; Rachel Steele PharmD, BCACP; and Ashley Parrott PharmD, MBA, BCPS, BCACP
Submissions from 2018
Sugammadex vs. neostigmine vs. spontaneous reversal in pulmonary complications post surgery, Allison Clemens PharmD
Implementation of a pharmacist-guided procalcitonin protocol in a community hospital, Jasmine Coatie PharmD
Implementation of a pilot program for medication-assisted treatment in the emergency department, Jenna Deininger PharmD
Impact of clinical guideline implementation of adult ketamine dosing in the emergency department, Julia Dickman PharmD
Effect of compliance of enhanced recovery after surgery protocols on pain control at a community medical center, Julia Dickman PharmD; Stacy Clore PharmD, BCPS; Jamie Gaul PharmD, BCPS; and Sarah Fitzpatrick PharmD, BCPS
Hypothermia protocol, Jason Eakins PharmD
Vancomycin Dosing: Bayesian derived AUC/MIC vs. trough only monitoring, Meagan Ellinger PharmD
Implementation of non-opioid order panels in Parkview Health emergency departments, Brandon James Euen
Impact of Sepsis Order Set Updates on Carbapenem Utilization in a Community Regional Medical Center, Brandon Euen PharmD; Michele Walters PharmD, BCPS, AQ-ID; and Luke Keller PharmD, BCPS, BCCCP
Implementation and evaluation of a pharmacy driven stress ulcer discontinuation protocol, Michael Genday PharmD
Evaluation of a hospital-based pharmacist-driven transitions of care service, Jordan Holder PharmD
Impact of customized response options on medication alert salience, Alissa Keillor PharmD
Ketamine dosing for sedation in mechanically ventilated patients, Zsanett Kormanyos PharmD
Impact of clinical pathways on antibiotic prescribing in the outpatient setting, Ashley Logan PharmD
Evaluation of pharmacist involvement in outpatient transitional care management, Katharine Lundy PharmD
Evaluation of bleeding and thrombotic risk in patients receiving triple antithrombotic therapy, Katharine Lundy PharmD; Elizabeth Meisberger PharmD, BCPS; Kris Howard PharmD, BCPS, AACC; and Jennifer Sposito PharmD
Impact of body weight on hemodynamic response to fixed dose vasopressin in septic shock, Corissa Piatka
Evaluation of prothrombin complex concentrate use in a community health system, Corissa L. Piatka PharmD; Tim Johnston PharmD, BCPS, BCCCP; and Jim Roy PharmD, BCPS, BCCCP
Addition of midodrine in ICU patients and the impact on vasopressor tapering, Leslie Siegel PharmD
Impact of restriction criteria on optimal ertapenem use in a community health system, Curtis Stump PharmD
Impact of rapid identification of gram negative blood cultures in a community hospital system, Carley Thompson PharmD
Evaluation of a pharmacist direct oral anticoagulant (DOAC) monitoring service, Priya Verma PharmD
Submissions from 2017
Use of steroids for early stage ARDS in ICU patients, Jasmine Coatie PharmD, Michael Todt PharmD, and Megan Straub PharmD
Characterization of Rapid Sequence Intubation in the Emergency Department, Jason P. Eakins PharmD; William Armstrong PharmD, BCPS; Bryan Statz PharmD; and Sarah E. Sienko PharmD
Evaluating prescribing patterns of long-acting injectable antipsychotics at a community health system, Chelsea L Ferguson PharmD; Jamie Gaul PharmD, BCPS; and Jared Netley PharmD
Methicillin-susceptible Staphylococcus aureus: Utilization of decolonization protocol and incidence of surgical site infections in orthopedic and cardiac bypass surgical patients, Carley Thompson PharmD; Tara Jellison PharmD, MBA, FASHP; and Jennifer Sposito PharmD